{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:39:53Z","timestamp":1773373193119,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T00:00:00Z","timestamp":1362528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00432-013-1408-2","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T07:24:16Z","timestamp":1362468256000},"page":"987-994","source":"Crossref","is-referenced-by-count":17,"title":["Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma"],"prefix":"10.1007","volume":"139","author":[{"given":"Krishna","family":"Pillai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hossein","family":"Pourgholami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence C.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Lawson","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,6]]},"reference":[{"key":"1408_CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/030089160308900307","volume":"89","author":"YI Acherman","year":"2003","unstructured":"Acherman YI, Welch LS, Bromley CM et al (2003) Clinical presentation of peritoneal mesothelioma. Tumori 89:269\u2013273","journal-title":"Tumori"},{"key":"1408_CR2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1752-1947-2-121","volume":"2","author":"I Ahmed","year":"2008","unstructured":"Ahmed I, Koulaouzidis A, Iqbal J et al (2008) Malignant peritoneal mesothelioma as a rare cause of ascites: a case report. J Med Case Rep 2:121","journal-title":"J Med Case Rep"},{"key":"1408_CR3","first-page":"155","volume":"11","author":"DC Allred","year":"1998","unstructured":"Allred DC, Harvey JM, Berardo M et al (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155\u2013168","journal-title":"Mod Pathol"},{"key":"1408_CR4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1200\/JCO.1988.6.1.147","volume":"6","author":"K Antman","year":"1988","unstructured":"Antman K, Shemin R, Ryan L et al (1988) Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital experience over two decades, 1965\u20131985. J Clin Oncol 6:147\u2013153","journal-title":"J Clin Oncol"},{"key":"1408_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1245\/s10434-009-0756-2","volume":"17","author":"D Baratti","year":"2010","unstructured":"Baratti D, Kusamura S, Cabras AD et al (2010) Lymph node metastases in diffuse malignant peritoneal mesothelioma. Ann Surg Oncol 17:45\u201353","journal-title":"Ann Surg Oncol"},{"key":"1408_CR6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2010.30.2075","volume":"29","author":"SK Bechis","year":"2011","unstructured":"Bechis SK, Carroll PR, Cooperberg MR (2011) Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol 29:235\u2013241","journal-title":"J Clin Oncol"},{"key":"1408_CR7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdl345","volume":"18","author":"P Boffetta","year":"2007","unstructured":"Boffetta P (2007) Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 18:985\u2013990","journal-title":"Ann Oncol"},{"key":"1408_CR8","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ejca.2005.04.008","volume":"41","author":"A Cavallini","year":"2005","unstructured":"Cavallini A, Notarnicola M, Giannini R et al (2005) Oestrogen receptor-related receptor alpha (ERRalpha) and oestrogen receptors (ERalpha and ERbeta) exhibit different gene expression in human colorectal tumour progression. Eur J Cancer 41:1487\u20131494","journal-title":"Eur J Cancer"},{"key":"1408_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.febslet.2004.04.025","volume":"566","author":"J Cheng","year":"2004","unstructured":"Cheng J, Lee EJ, Madison LD et al (2004) Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett 566:169\u2013172","journal-title":"FEBS Lett"},{"key":"1408_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jso.21177","volume":"99","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Morris DL (2009) Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience. J Surg Oncol 99:109\u2013113","journal-title":"J Surg Oncol"},{"key":"1408_CR11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1245\/ASO.2006.03.045","volume":"13","author":"M Deraco","year":"2006","unstructured":"Deraco M, Nonaka D, Baratti D et al (2006) Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 13:229\u2013237","journal-title":"Ann Surg Oncol"},{"key":"1408_CR12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4251\/wjgo.v2.i2.76","volume":"2","author":"M Deraco","year":"2010","unstructured":"Deraco M, Baratti D, Cabras AD et al (2010) Experience with peritoneal mesothelioma at the Milan National Cancer Institute. World J Gastrointest Oncol 2:76\u201384","journal-title":"World J Gastrointest Oncol"},{"key":"1408_CR13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<6::AID-JSO2>3.0.CO;2-X","volume":"70","author":"GH Eltabbakh","year":"1999","unstructured":"Eltabbakh GH, Piver MS, Hempling RE et al (1999) Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 70:6\u201312","journal-title":"J Surg Oncol"},{"key":"1408_CR14","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","volume":"17","author":"JM Harvey","year":"1999","unstructured":"Harvey JM, Clark GM, Osborne CK et al (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17:1474\u20131481","journal-title":"J Clin Oncol"},{"key":"1408_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1677\/erc.0.0100193","volume":"10","author":"SI Hayashi","year":"2003","unstructured":"Hayashi SI, Eguchi H, Tanimoto K et al (2003) The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application. Endocr Relat Cancer 10:193\u2013202","journal-title":"Endocr Relat Cancer"},{"key":"1408_CR16","first-page":"17","volume":"14","author":"N Jassam","year":"2005","unstructured":"Jassam N, Bell SM, Speirs V et al (2005) Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes\u2019 staging. Oncol Rep 14:17\u201321","journal-title":"Oncol Rep"},{"key":"1408_CR17","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1158\/1078-0432.CCR-05-0200","volume":"11","author":"H Kawai","year":"2005","unstructured":"Kawai H, Ishii A, Washiya K et al (2005) Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res 11:5084\u20135089","journal-title":"Clin Cancer Res"},{"key":"1408_CR18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anndiagpath.2012.05.007","volume":"17","author":"Y Kinoshita","year":"2013","unstructured":"Kinoshita Y, Takasu K, Yuri T et al (2013) Two cases of malignant peritoneal mesothelioma without asbestos exposure: cytologic and immunohistochemical features. Ann Diagn Pathol 17:99\u2013103","journal-title":"Ann Diagn Pathol"},{"key":"1408_CR19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1210\/me.2010-0469","volume":"25","author":"KR Lamont","year":"2011","unstructured":"Lamont KR, Tindall DJ (2011) Minireview: alternative activation pathways for the androgen receptor in prostate cancer. Mol Endocrinol 25:897\u2013907","journal-title":"Mol Endocrinol"},{"key":"1408_CR20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1677\/ERC-09-0294","volume":"17","author":"YK Leung","year":"2010","unstructured":"Leung YK, Lam HM, Wu S et al (2010) Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. Endocr Relat Cancer 17:675\u2013689","journal-title":"Endocr Relat Cancer"},{"key":"1408_CR21","doi-asserted-by":"crossref","first-page":"24353","DOI":"10.1074\/jbc.M201829200","volume":"277","author":"MM Liu","year":"2002","unstructured":"Liu MM, Albanese C, Anderson CM et al (2002) Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem 277:24353\u201324360","journal-title":"J Biol Chem"},{"key":"1408_CR22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/annonc\/mdp307","volume":"21","author":"P Manzini Vde","year":"2010","unstructured":"Manzini Vde P, Recchia L, Cafferata M et al (2010) Malignant peritoneal mesothelioma: a multicenter study on 81 cases. Ann Oncol 21:348\u2013353","journal-title":"Ann Oncol"},{"key":"1408_CR23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/A:1015764507609","volume":"13","author":"RM Merrill","year":"2002","unstructured":"Merrill RM, Bird JS (2002) Effect of young age on prostate cancer survival: a population-based assessment (United States). Cancer Causes Control 13:435\u2013443","journal-title":"Cancer Causes Control"},{"key":"1408_CR24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002920050340","volume":"20","author":"V Neumann","year":"1999","unstructured":"Neumann V, Muller KM, Fischer M (1999) Peritoneal mesothelioma\u2013incidence and etiology. Pathologe 20:169\u2013176","journal-title":"Pathologe"},{"key":"1408_CR25","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1158\/1078-0432.CCR-07-1950","volume":"14","author":"H Niikawa","year":"2008","unstructured":"Niikawa H, Suzuki T, Miki Y et al (2008) Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma. Clin Cancer Res 14:4417\u20134426","journal-title":"Clin Cancer Res"},{"key":"1408_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1677\/jme.0.0300013","volume":"30","author":"B Peng","year":"2003","unstructured":"Peng B, Lu B, Leygue E et al (2003) Putative functional characteristics of human estrogen receptor-beta isoforms. J Mol Endocrinol 30:13\u201329","journal-title":"J Mol Endocrinol"},{"key":"1408_CR27","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1158\/0008-5472.CAN-08-4523","volume":"69","author":"G Pinton","year":"2009","unstructured":"Pinton G, Brunelli E, Murer B et al (2009) Estrogen receptor-beta affects the prognosis of human malignant mesothelioma. Cancer Res 69:4598\u20134604","journal-title":"Cancer Res"},{"key":"1408_CR28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","volume":"366","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Musk AW, Lake RA (2005) Malignant mesothelioma. Lancet 366:397\u2013408","journal-title":"Lancet"},{"key":"1408_CR29","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/1097-0142(19921215)70:12<2969::AID-CNCR2820701239>3.0.CO;2-A","volume":"70","author":"KS Sridhar","year":"1992","unstructured":"Sridhar KS, Doria R, Raub WA Jr et al (1992) New strategies are needed in diffuse malignant mesothelioma. Cancer 70:2969\u20132979","journal-title":"Cancer"},{"key":"1408_CR30","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1517\/14656560903044974","volume":"10","author":"PH Sugarbaker","year":"2009","unstructured":"Sugarbaker PH (2009) Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach. Expert Opin Pharmacother 10:1965\u20131977","journal-title":"Expert Opin Pharmacother"},{"key":"1408_CR31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.critrevonc.2008.03.005","volume":"67","author":"BL Leeuwen van","year":"2008","unstructured":"van Leeuwen BL, Pahlman L, Gunnarsson U et al (2008) The effect of age and gender on outcome after treatment for colon carcinoma. A population-based study in the Uppsala and Stockholm region. Crit Rev Oncol Hematol 67:229\u2013236","journal-title":"Crit Rev Oncol Hematol"},{"key":"1408_CR32","first-page":"617","volume":"11","author":"IS Woo","year":"2004","unstructured":"Woo IS, Park MJ, Choi SW et al (2004) Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines. Oncol Rep 11:617\u2013622","journal-title":"Oncol Rep"},{"key":"1408_CR33","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jtcvs.2005.06.012","volume":"130","author":"CT Wu","year":"2005","unstructured":"Wu CT, Chang YL, Shih JY et al (2005) The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg 130:979\u2013986","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1408_CR34","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/bjs.5377","volume":"93","author":"TD Yan","year":"2006","unstructured":"Yan TD, Popa E, Brun EA et al (2006) Sex difference in diffuse malignant peritoneal mesothelioma. Br J Surg 93:1536\u20131542","journal-title":"Br J Surg"},{"key":"1408_CR35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1245\/s10434-006-9169-7","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Brun EA, Cerruto CA et al (2007) Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol 14:41\u201349","journal-title":"Ann Surg Oncol"},{"key":"1408_CR36","first-page":"2306","volume":"37","author":"Y Yonemura","year":"2010","unstructured":"Yonemura Y, Tsukiyama G, Miyata R et al (2010) Indication of peritonectomy for peritoneal dissemination. Gan To Kagaku Ryoho 37:2306\u20132311","journal-title":"Gan To Kagaku Ryoho"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-013-1408-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-013-1408-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-013-1408-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T09:04:36Z","timestamp":1562749476000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-013-1408-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["1408"],"URL":"https:\/\/doi.org\/10.1007\/s00432-013-1408-2","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,6]]}}}